Application of 18F-PSMA-1007 PET/MR Imaging in Early Biochemical Recurrence of Prostate Cancer: Results of a Prospective Study of 60 Patients with Very Low PSA Levels ≤ 0.5 ng/mL

Application of 18F-PSMA-1007 PET/MR Imaging in Early Biochemical Recurrence of Prostate Cancer: Results of a Prospective Study of 60 Patients with Very Low PSA Levels ≤ 0.5 ng/mL

The use of 18F-PSMA-1007 and the role of PET/MR in the diagnosis of prostate cancer are not conclusively confirmed. There are reports indicating the potential pros and cons of using 18F-PSMA-1007 as well as the PET/MR technique in prostate cancer recurrence, but they are not yet included in the EAU...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cancers 2023-08, Vol.15 (16), p.4185
Hauptverfasser: Mojsak, Małgorzata, Szumowski, Piotr, Amelian, Anna, Hladunski, Marcin, Kubas, Bożena, Myśliwiec, Janusz, Kochanowicz, Jan, Moniuszko, Marcin
Format: Artikel
Sprache:eng
Schlagworte:
Cancer
Diagnosis
Diseases
Good Manufacturing Practice
Lesions
Ligands
Localization
Lymph nodes
Lymphatic system
Magnetic resonance imaging
Metastases
Oncology, Experimental
Patients
Pelvis
Prostate cancer
Prostatectomy
Quality of life
Radiation therapy
Radioisotopes
Relapse
Scanners
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The use of 18F-PSMA-1007 and the role of PET/MR in the diagnosis of prostate cancer are not conclusively confirmed. There are reports indicating the potential pros and cons of using 18F-PSMA-1007 as well as the PET/MR technique in prostate cancer recurrence, but they are not yet included in the EAU guidelines. The aim of the study was to assess the effectiveness of 18F-PSMA-1007 PET/MR in detecting BCR lesions at very low PSA levels
ISSN:2072-6694
2072-6694
DOI:10.3390/cancers15164185